Blood consult: Therapeutic strategy and complications in the adolescent and young adult with acute lymphoblastic leukemia

Blood

Volumn 119, Issue 19, 2012, Pages 4372-4374

  Nakano, Taizo A ^a   Hunger, Stephen P ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE MACROGOL; DAUNORUBICIN; HEMOGLOBIN; METHOTREXATE; PREDNISONE; TRIACYLGLYCEROL LIPASE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADL DISABILITY; ADULT; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; CHOLANGITIS; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 4; CONSOLIDATION CHEMOTHERAPY; CYTOGENETICS; DRUG MEGADOSE; FATIGUE; FATTY LIVER; FEMALE; FEVER; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GALLSTONE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; INDUCTION CHEMOTHERAPY; INSULIN TREATMENT; LEUKEMIA CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LIVER TOXICITY; LUMBAR PUNCTURE; NAUSEA; OUTPATIENT CARE; PANCREATITIS; PANCYTOPENIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; TRISOMY; WEAKNESS;

EID: 84860893280     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-367128     Document Type: Article

References (11)

1. Larsen EC, Salzer WL, Devidas M, et al. High dose methotrexate (HD-MTX) as compared to Capizzi methotrexate plus asparaginase (C-MTX/ASNase) improves event-free survival (EFS) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): a report from the Children's Oncology Group study AALL0232 [abstract]. J Clin Oncol. 2011;29(suppl ASCO 2011 Plenary Session presentation):6s, Abstract 3.
2. Schafer ES, Hunger SP. Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults. Nat Rev Clin Oncol. 2011;8(7):417-424.
3. Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol. 2009;144(2):147-156.
4. Stock W, Douer D, DeAngelo DJ, et al. Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leuk Lymphoma. 2011;52(12): 2237-2253.
5. Barry E, DeAngelo DJ, Neuberg D, et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol. 2007;25(7):813-819. (Pubitemid 350002881)
6. Nachman JB, La MK, Hunger SP, et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the Children's Oncology Group. J Clin Oncol. 2009;27(31):5189-5194.
7. Pui CH, Pei D, Campana D, et al. Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol. 2011;29(4):386-391.
8. Ribera JM, Oriol A, Sanz MA, et al. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanõl de Tratamiento en Hematología Pediatric-Based Protocol ALL-96. J Clin Oncol. 2008;26(11):1843-1849.
9. Nachman JB. Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia. Br J Haematol. 2005;130(2):166-173.
10. Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B Studies. Blood. 2008;122(5):1646-1654.
11. Seibel NL, Steinherz PG, Sather HN, et al. Early postinduction intensification therapy improves survival for children and adolescents with highrisk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2008; 111(5):2548-2555.